Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects
Open accessThe DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Abstract
Exposure to drugs during pregnancy has the potential to harm offspring. Teratogenic effects are the most feared adverse outcomes in newborns; however, a wide spectrum of less known, usually reversible and often acute, neonatal adverse events can also occur due to drug intake by mothers during pregnancy, particularly in close proximity to delivery. This narrative review is aimed at the description of drugs and drug classes for which licit maternal use in the predelivery period has been associated with neonatal non-teratogenic disorders. For each drug class, epidemiology, clinical features, biological mechanism and management of these adverse reactions have been discussed in detail. Although these adverse reactions have been described mainly for substances used illicitly for recreational purposes, several prescription drugs have also been involved; these include mainly psychotropic medications such as opioids, antidepressants, antiepileptics and antipsychotics. These effects can be partly explained by withdrawal syndromes (defined also as 'neonatal abstinence syndrome') caused by the delivery-related discontinuation of the drug disposition from the mother to the fetus, with symptoms that may include feeding disorders, tremors, irritability, hypotonia/hypertonia, vomiting and persistent crying, occurring a few hours to 1 month after delivery. Otherwise, neonatal neurological and behavioral effects can also be caused by a residual pharmacological effect due to an accumulation of the drug in the blood and tissues of the newborn, with various symptoms related to the toxic effects of the specific drug class, usually developing a few hours after birth. With few exceptions, validated protocols for the assessment and management of withdrawal or residual pharmacological effects of these drugs in neonates are often lacking or incomplete. Spontaneous reporting of these adverse reactions seems limited, although it might represent a useful tool for improving our knowledge about drug-induced neonatal syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both neonatal BZD withdrawal and FIS typically present within the first hours of life and continue for up to 14 days.184”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [184]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Floppy infant syndrome (FIS)—which presents with hypotonia, lethargy, sucking difficulties, low Apgar score, hypothermia, apnea, cyanosis, hyperbilirubinemia, and CNS depression—has also been observed in newborns who have been exposed to BZDs in utero during the third trimester and may be a result of BZD toxicity.184,185”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Epidemiology of Puerperal Psychoses
Kendell, R. E., Chalmers, J. C., & Platz, C. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.5.662 · Cited by 1,119
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012) · JAMA · doi:10.1001/jama.2012.3951 · Cited by 907
Hudak, M. L., Tan, R. C., THE COMMITTEE ON DRUGS, THE COMMITTEE ON FETUS AND NEWBORN, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Neville, K. A., Paul, I. M., Van Den Anker, J. N., et al. (2012) · Pediatrics · doi:10.1542/peds.2011-3212 · Cited by 877
Neonatal abstinence syndrome: assessment and management.
Finnegan, L. P., Connaughton, J. F., Kron, R. E., & Jp, E. (1975) · PubMed · Cited by 664
Kocherlakota, P. (2014) · Pediatrics · doi:10.1542/peds.2013-3524 · Cited by 612 · cited 6×
“In the most severe situations, pharmacological treatment can be required [2].”
BackgroundMethodInfluentialOberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Moses-Kolko, E. L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 533
Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000 to 2009
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2013) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000429117.48176.cc · Cited by 454
Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUs
Tolia, V. N., Patrick, S. W., Bennett, M. M., Murthy, K., Sousa, J., Smith, P. B., Clark, R. H., & Spitzer, A. R. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1500439 · Cited by 434
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427 · cited 4×
“when necessary physicians should prescribe benzodiazepines that have more robust safety data, in monotherapy, at the lowest effective dose for the shortest period of time, dividing the daily dose into at least two doses and avoiding high single doses, multidrug regimens, and repeated and prolonged administration of be…”
BackgroundInfluentialSanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Maternal treatment with opioid analgesics and risk for birth defects
Broussard, C. S., Rasmussen, S. A., Reefhuis, J., Friedman, J. M., Jann, M. W., Riehle-Colarusso, T., & Honein, M. A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.12.039 · Cited by 372
Dolovich, L. R., Addis, A., Vaillancourt, J. M. R., Power, J. D. B., Koren, G., & Einarson, T. R. (1998) · BMJ · doi:10.1136/bmj.317.7162.839 · Cited by 353
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 331
Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.2.173 · Cited by 329
Pregnancy Outcome of Women Using Atypical Antipsychotic Drugs: A Prospective Comparative Study
McKenna, K., Koren, G., Tetelbaum, M., Wilton, L., Shakir, S., Diav-Citrin, O., Levinson, A., Zipursky, R. B., & Einarson, A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0406 · Cited by 312
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303 · cited 1×
“condition of withdrawal similar to that observed in adults [145].”
ResultNeonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy
Källén, B. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.4.312 · Cited by 300
Pharmacological causes of hyperprolactinemia.
Torre, D. L., & Falorni, A. (2007) · PubMed Central · Cited by 287
The Impact of Reproductive Events on the Course of Bipolar Disorder in Women
Freeman, M. P., Smith, K. W., Freeman, S. A., McElroy, S. L., Kmetz, G. F., Wright, R., & Keck, P. E. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0403 · Cited by 287
Perinatal Outcome Following Third Trimester Exposure to Paroxetine
Costei, A. M., Kozer, E., Ho, T., Ito, S., & Koren, G. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.11.1129 · Cited by 270
Abdel-Latif, M. E., Pinner, J., Clews, S., Cooke, F., Lui, K., & Oei, J. (2006) · Pediatrics · doi:10.1542/peds.2005-1561 · Cited by 266
The effects of benzodiazepine use during pregnancy and lactation
McElhatton, P. R. (1994) · Reproductive Toxicology · doi:10.1016/0890-6238(94)90029-9 · Cited by 265
Newport, D. J., Calamaras, M. R., DeVane, C. L., Donovan, J., Beach, A. J., Winn, S., Knight, B. T., Gibson, B. B., Viguera, A. C., Owens, M. J., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111886 · Cited by 257
Placental Transfer of SSRI and SNRI Antidepressants and Effects on the Neonate
Rampono, J., Simmer, K., Ilett, K. F., Hackett, L. P., Doherty, D. A., Elliot, R., Kok, C. H., Coenen, A., & Forman, T. (2009) · Pharmacopsychiatry · doi:10.1055/s-0028-1103296 · Cited by 254
Wikner, B. N., Stiller, C., Bergman, U., Asker, C., & Källén, B. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1457 · Cited by 253
Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth
Dean, J. C. S., Hailey, H., Moore, S. J., Lloyd, D. J., Turnpenny, P. D., & Little, J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.251 · Cited by 252
Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review
Gentile, S. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn107 · Cited by 247
The opioid-exposed newborn: Assessment and pharmacologic management
Jansson, M., Velez, M., & Harrow, R.-L. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0006 · Cited by 247
ACOG Practice Bulletin No. 92: Use of Psychiatric Medications During Pregnancy and Lactation
(2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31816fd910 · Cited by 246
Use of buprenorphine in pregnancy: patient management and effects on the neonate
JOHNSON, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00062-0 · Cited by 245
Oberlander, T. F., Misri, S., Fitzgerald, C. E., Kostaras, X., Rurak, D., & Riggs, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0214 · Cited by 244
Lejeune, C., Simmat-Durand, L., Gourarier, L., & Aubisson, S. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.10.001 · Cited by 239
Committee on Drugs (1998) · PEDIATRICS · doi:10.1542/peds.101.6.1079 · Cited by 234
Dryden, C., Young, D., Hepburn, M., & Mactier, H. (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.02073.x · Cited by 230
Nau, H., Rating, D., Koch, S., Häuser, I., & Helge, H. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32875-2 · Cited by 230
Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome
Reis, M., & Källén, B. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b8d5 · Cited by 225
(2010) · PubMed · Cited by 212
Lipsitz, P. J. (1975) · Clinical Pediatrics · doi:10.1177/000992287501400613 · Cited by 206
Cree, J. E., Meyer, J., & Hailey, D. M. (1973) · BMJ · doi:10.1136/bmj.4.5887.251 · Cited by 204
Davis, R. L., Rubanowice, D., McPhillips, H., Raebel, M. A., Andrade, S. E., Smith, D., Yood, M. U., & Platt, R. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1462 · Cited by 203
Best Practice Guidelines for the Management of Women with Epilepsy
Crawford, P. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00323.x · Cited by 203
PARKINSON, T. (1947) · PubMed · Cited by 199
Engeland, A., Bramness, J. G., Daltveit, A. K., Rønning, M., Skurtveit, S., & Furu, K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03102.x · Cited by 197
Wachman, E. M., Hayes, M. J., Brown, M. S., Paul, J., Harvey-Wilkes, K., Terrin, N., Huggins, G. S., Aranda, J. V., & Davis, J. M. (2013) · JAMA · doi:10.1001/jama.2013.3411 · Cited by 197
METHYLDOPA AND HqMOLYTIC ANqMIA
WEINER, W. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92290-2 · Cited by 195
Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey
Sarkar, S., & Donn, S. M. (2006) · Journal of Perinatology · doi:10.1038/sj.jp.7211427 · Cited by 194
Withdrawal syndromes associated with antipsychotic drugs
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1321 · Cited by 191
Methadone dose and neonatal abstinence syndrome—systematic review and meta‐analysis
Cleary, B. J., Donnelly, J., Strawbridge, J., Gallagher, P. J., Fahey, T., Clarke, M., & Murphy, D. J. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03120.x · Cited by 187
(2018) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610021494-part05-neonatal_drug_withdr · Cited by 185
Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
Nordeng, H., Lindemann, R., Perminov, K. V., & Reikvam1, Å. (2001) · Acta Paediatrica · doi:10.1080/080352501300067596 · Cited by 181
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Eady, A., Tomlinson, G., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07967 · Cited by 180
Huang, H., Coleman, S., Bridge, J. A., Yonkers, K., & Katon, W. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.08.002 · Cited by 180
Agthe, A. G., Kim, G. R., Mathias, K. B., Hendrix, C. W., Chavez-Valdez, R., Jansson, L., Lewis, T. R., Yaster, M., & Gauda, E. B. (2009) · Pediatrics · doi:10.1542/peds.2008-0978 · Cited by 178
Desai, R. J., Huybrechts, K. F., Hernandez-Diaz, S., Mogun, H., Patorno, E., Kaltenbach, K., Kerzner, L. S., & Bateman, B. T. (2015) · BMJ · doi:10.1136/bmj.h2102 · Cited by 174
Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring
Kandall, S. R., Gaines, J., Habel, L., Davidson, G., & Jessop, D. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81554-9 · Cited by 172
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants
Welle-Strand, G. K., Skurtveit, S., Jansson, L. M., Bakstad, B., Bjarkø, L., & Ravndal, E. (2013) · Acta Paediatrica · doi:10.1111/apa.12378 · Cited by 169
Use and Safety of Antipsychotic Drugs During Pregnancy
Einarson, A., & Boskovic, R. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000351878.45260.94 · Cited by 167
Neonatal opiate abstinence syndrome in term and preterm infants
Doberczak, T. M., Kandal, S. R., & Wilets, I. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82214-0 · Cited by 165
Management of neonatal abstinence syndrome in neonates born to opioid maintained women
Ebner, N., Rohrmeister, K., Winklbaur, B., Baewert, A., Jagsch, R., Peternell, A., Thau, K., & Fischer, G. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.08.024 · Cited by 165
Psychotropic Drug Directory 1993
Montgomery, S. A. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300820-00011 · Cited by 165
Olanzapine-Exposed Pregnancies and Lactation: Early Experience
Goldstein, D. J., Corbin, L. A., & Fung, M. C. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00002 · Cited by 163
Review of the assessment and management of neonatal abstinence syndrome
Bagley, S. M., Wachman, E. M., Holland, E., & Brogly, S. B. (2014) · Addiction Science & Clinical Practice · doi:10.1186/1940-0640-9-19 · Cited by 162
Withdrawal symptoms in neonates from intrauterine exposure to diazepam
Rementería, J. L., & Bhatt, K. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80785-3 · Cited by 159
Maternal barbiturate utilization and neonatal withdrawal symptomatology
Desmond, M. M., Schwanecke, R. P., Wilson, G. S., Yasunaga, S., & Burgdorff, I. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80577-8 · Cited by 156
Methadone Maintenance and Breastfeeding in the Neonatal Period
Jansson, L. M., Choo, R., Velez, M. L., Harrow, C., Schroeder, J. R., Shakleya, D. M., & Huestis, M. A. (2008) · Pediatrics · doi:10.1542/peds.2007-1182 · Cited by 154
Periconceptional Use of Opioids and the Risk of Neural Tube Defects
Yazdy, M. M., Mitchell, A. A., Tinker, S. C., Parker, S. E., & Werler, M. M. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182a6643c · Cited by 150
Maternal methadone dose and neonatal withdrawal
Berghella, V., Lim, P. J., Hill, M., Cherpes, J., Chennat, J. S., & Kaltenbach, K. A. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00520-9 · Cited by 150
Opioid Dependency in Pregnancy and Length of Stay for Neonatal Abstinence Syndrome
Pritham, U. A., Paul, J. A., & Hayes, M. J. (2012) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2011.01330.x · Cited by 149
Opioids in pregnancy and neonatal abstinence syndrome
Stover, M. W., & Davis, J. M. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.08.013 · Cited by 148
Maldonado, R. J., Negus, S. S., & Koob, G. F. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90051-p · Cited by 147
Öhman, I., Vitols, S., & Tomson, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00251.x · Cited by 141
Ferreira, E., Carceller, A. M., Agogué, C., Martin, B. Z., St-André, M., Francoeur, D., & Bérard, A. (2007) · Pediatrics · doi:10.1542/peds.2006-2133 · Cited by 135
Protective effect of pregnancy in women with lithium-responsive bipolar disorder
Grof, P., Robbins, W., Alda, M., Berghoefer, A., Vojtĕchovský, M., Nilsson, A., & Robertson, C. A. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00197-4 · Cited by 135
Maintenance agonist treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub2 · Cited by 134
Antidepressant Discontinuation Syndrome
(2017) · The SAGE Encyclopedia of Abnormal and Clinical Psychology · doi:10.4135/9781483365817.n77 · Cited by 134
Complications during pregnancy in women with epilepsy: population‐based cohort study
Borthen, I., Eide, M. G., Veiby, G., Daltveit, A. K. N., & Ne, G. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02354.x · Cited by 132
Warburton, W., Hertzman, C., & Oberlander, T. F. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01490.x · Cited by 128
Rates of Mental Disease Related to Childbearing
Pugh, T. F., Jerath, B. K., Schmidt, W. M., & Reed, R. B. (1963) · New England Journal of Medicine · doi:10.1056/nejm196305302682205 · Cited by 128
Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk
Hendrick, V. C., Stowe, Z. N., Altshuler, L. L., Mintz, J., Hwang, S., Hostetter, A. L., Suri, R., Leight, K. L., & Fukuchi, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01197-0 · Cited by 126
Kanto, J. (1982) · Drugs · doi:10.2165/00003495-198223050-00002 · Cited by 121
The Neonatal Withdrawal Inventory: A Simplified Score of Newborn Withdrawal
ZAHORODNY, W., ROM, C., WHITNEY, W., GIDDENS, S., SAMUEL, M., MAICHUK, G., & MARSHALL, R. (1998) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199804000-00005 · Cited by 120
Coyle, M. G., Ferguson, A. E., LaGasse, L. L., Oh, W., & Lester, B. M. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.123099 · Cited by 117
Maintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Bellisario, C., Ferri, M., & Davoli, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub3 · Cited by 116
Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Trial
Kraft, W. K., Gibson, E., Dysart, K., Damle, V. S., LaRusso, J., Greenspan, J. S., Moody, D. E., Kaltenbach, K. A., & Ehrlich, M. E. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0571 · Cited by 114
Opioid abuse and brain gene expression
Przewłocki, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.036 · Cited by 111
Leo, R. J., & Baer, D. (2005) · Psychosomatics · doi:10.1176/appi.psy.46.6.503 · Cited by 107
Coppola, D., Russo, L., Kwarta, R. F., Varughese, R., & Schmider, J. (2007) · Drug Safety · doi:10.2165/00002018-200730030-00006 · Cited by 107
Kulkarni, J., Worsley, R., Gilbert, H., Gavrilidis, E., Rheenen, T. E. V., Wang, W., McCauley, K., & Fitzgerald, P. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094788 · Cited by 107
Olivier, J. D. A., Åkerud, H., Kaihola, H., Pawluski, J. L., Skalkidou, A., Högberg, U., & Sundström-Poromaa, I. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00073 · Cited by 107
Rampono, J., Proud, S., Hackett, L. P., Kristensen, J. H., & Ilett, K. F. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004286 · Cited by 107
Prenatal Antipsychotic Exposure and Neuromotor Performance During Infancy
Johnson, K. C., LaPrairie, J. L., Brennan, P. A., Stowe, Z. N., & Newport, D. J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.160 · Cited by 107
A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome
Jackson, L., Ting, A., Mckay, S., Galea, P., & Skeoch, C. (2004) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2003.033555 · Cited by 105
Effect of maternal lorazepam on the neonate.
Whitelaw, A. G., Cummings, A. J., & McFadyen, I. R. (1981) · BMJ · doi:10.1136/bmj.282.6270.1106 · Cited by 104 · cited 2×
“diazepam and clorazepate) can be converted into active compounds with a longer half-life than those produced by maternal metabolism [211, 215, 229, 249].”
BackgroundAntiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome
Koch, S., Jäger‐Roman, E., Lösche, G., Nau, H., Rating, D., & Helge, H. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14137.x · Cited by 103
Effects of exposure to benzodiazepine during fetal life
Bergman, U., Wiholm, B.-E., Rosa, F. W., Baum, C., Faich, G. A., & Wiholm, B.-E. (1992) · The Lancet · doi:10.1016/0140-6736(92)92232-5 · Cited by 101
The use of psychotropic medication during pregnancy: how about the newborn?
Kieviet, N., Honig, & Dolman (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36394 · Cited by 100 · cited 10×
“Should the syndrome develop fully, supportive care must be provided [101, 102, 106, 135, 150, 151].”
BackgroundResultInfluentialDo maternal opioids reduce neonatal regional brain volumes? A pilot study
Yuan, Q., Rubic, M., Seah, J., Rae, C. D., Wright, I. M. R., Kaltenbach, K. A., Feller, J. M., Abdellatif, M., Chu, C., Oei, J. L., et al. (2014) · Journal of Perinatology · doi:10.1038/jp.2014.111 · Cited by 100
Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
Thisted, E., & Ebbesen, F. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.69.3_spec_no.288 · Cited by 100
Koren, G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041100 · Cited by 100
Epigenetic Variation in the Mu-Opioid Receptor Gene in Infants with Neonatal Abstinence Syndrome
Wachman, E. M., Hayes, M. J., Lester, B. M., Terrin, N., Brown, M. S., Nielsen, D. A., & Davis, J. M. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.05.040 · Cited by 100
First admission with puerperal psychosis: 7–14 years of follow‐up
Videbech, P., & Gouliaev, G. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09761.x · Cited by 98
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
Stahl, M. M. S., Lindquist, M., Pettersson, M., Edwards, I. R., Sanderson, J. H., Taylor, N. F. A., Fletcher, A. P., & Schou, J. S. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050357 · Cited by 97
Special considerations in treating bipolar disorder in women
Burt, V. K., & Rasgon, N. (2004) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00089.x · Cited by 95
Tuccori, M., Testi, A., Antonioli, L., Fornai, M., Montagnani, S., Ghisu, N., Colucci, R., Corona, T., Blandizzi, C., & Tacca, M. D. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.07.009 · Cited by 95
Self-citationNeonatal abstinence syndrome: Historical perspective, current focus, future directions
Jones, H. E., & Fielder, A. L. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.07.017 · Cited by 94
Kraft, W. K., Dysart, K., Greenspan, J. S., Gibson, E., Kaltenbach, K. A., & Ehrlich, M. E. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03170.x · Cited by 94
Neonatal neurobehavior effects following buprenorphine versus methadone exposure
Coyle, M. G., Salisbury, A. L., Lester, B. M., Jones, H. E., Lin, H., Graf‐Rohrmeister, K., & Fischer, G. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04040.x · Cited by 92
Family planning needs and STD risk behaviours of female psychiatric out-patients
Coverdale, J., Turbott, S. H., & Roberts, H. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.171.1.69 · Cited by 92
Bech, B. H., Kjaersgaard, M. I. S., Pedersen, H. S., Howards, P. P., Sørensen, M. J., Olsen, J. H., Parner, E. T., Pedersen, L. H., Vestergaard, M., & Christensen, J. (2014) · BMJ · doi:10.1136/bmj.g5159 · Cited by 92
Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy
Maas, U., Kattner, E., Weingart-Jesse, B., Schäfer, A., & Obladen, M. (1990) · jpme · doi:10.1515/jpme.1990.18.2.111 · Cited by 89
Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy
Jones, H. E., Dengler, E., Garrison, A., O’Grady, K. E., Seashore, C. J., Horton, E., Andringa, K., Jansson, L. M., & Thorp, J. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.11.006 · Cited by 89
Green, M., & Suffet, F. (1981) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998108999125 · Cited by 86
Surran, B., Visintainer, P., Chamberlain, S., Kopcza, K., Shah, B. L., & Singh, R. (2013) · Journal of Perinatology · doi:10.1038/jp.2013.95 · Cited by 86
"FLOPPY INFANT SYNDROME" AND MATERNAL DIAZEPAM
Gillberg, C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92855-0 · Cited by 86
Bobo, W. V., Davis, R. L., Toh, S., Li, D., Andrade, S. E., Cheetham, T. C., Pawloski, P. A., Dublin, S., Pinheiro, S. P., Hammad, T. A., et al. (2012) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12004 · Cited by 86
PLACENTAL TRANSFER OF PHENOBARBITONE IN EPILEPTIC WOMEN, AND ELIMINATION IN NEWBORNS
MELCHIOR, J. C., Svensmark, O., & Trolle, D. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92593-7 · Cited by 85
Klinger, G., Frankenthal, D., Merlob, P., Diamond, G. W., Sirota, L., Levinson-Castiel, R., Linder, N., Stahl, B., & Inbar, D. (2011) · Journal of Perinatology · doi:10.1038/jp.2010.211 · Cited by 84
The Impact of Infant Feeding Method on Neonatal Abstinence Scores of Methadone-Exposed Infants
McQueen, K. A., Murphy-Oikonen, J., Gerlach, K., & Montelpare, W. (2011) · Advances in Neonatal Care · doi:10.1097/anc.0b013e318225a30c · Cited by 83
Fetal and Neonatal Effects of Maternal Drug Treatment for Depression
Belik, J. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.08.001 · Cited by 77
Kuhnz, W., Koch, S., Helge, H., & Nau, H. (1988) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457682 · Cited by 75
Benzodiazepine Dependence: Avoidance and Withdrawal
Marriott, S., & Tyrer, P. (1993) · Drug Safety · doi:10.2165/00002018-199309020-00003 · Cited by 73
O'Connor, A. B., Collett, A., Alto, W. A., & O'Brien, L. M. (2013) · Journal of Midwifery & Women's Health · doi:10.1111/jmwh.12009 · Cited by 73
Buprenorphine in pregnant opioid‐dependent women: first results of a prospective study
Lacroix, I., Berrébi, A., Chaumerliac, C., Lapeyre‐Mestre, M., Montastruc, J., & Damase‐Michel, C. (2004) · Addiction · doi:10.1046/j.1360-0443.2003.00600.x · Cited by 72
Chlordiazepoxide withdrawal in the neonate
Athinarayanan, P., Pierog, S. H., Nigam, S., & Glass, L. (1976) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33306-3 · Cited by 71
Neonatal convulsions caused by withdrawal from maternal clomipramine.
Cowe, L., Lloyd, D. J., & Dawling, S. (1982) · BMJ · doi:10.1136/bmj.284.6332.1837-a · Cited by 71
Heikkinen, T. (2002) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(02)01467-2 · Cited by 71
Neonatal opioid withdrawal and antenatal opioid prescribing
Turner, S. D., Gomes, T., Camacho, X., Yao, Z., Guttmann, A., Mamdani, M., Juurlink, D. N., & Dhalla, I. A. (2015) · CMAJ Open · doi:10.9778/cmajo.20140065 · Cited by 71
Update on the pharmacologic management of neonatal abstinence syndrome
Bio, L. L., Siu, A., & Poon, C. Y. (2011) · Journal of Perinatology · doi:10.1038/jp.2011.116 · Cited by 70
Antiepileptic drugs and breastfeeding
Davanzo, R., Dal Bo, S., Bua, J., Copertino, M., Zanelli, E., & Matarazzo, L. (2013) · Italian Journal of Pediatrics · doi:10.1186/1824-7288-39-50 · Cited by 70
Forsberg, L., Navér, L., Gustafsson, L. L., & Wide, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111327 · Cited by 69
Fabiano, V., Mameli, C., & Zuccotti, G. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.584531 · Cited by 68
Neonatal apnea associated with maternal clonazepam therapy: a case report.
Fisher, J. B., Edgren, B. E., Mammel, M. C., & Coleman, J. M. (1985) · PubMed · Cited by 67
LIU, A. J. W., JONES, M. P., MURRAY, H., COOK, C., & NANAN, R. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2010.01168.x · Cited by 67
FLOPPY-INFANT SYNDROME AND MATERNAL DIAZEPAM AND/OR NITRAZEPAM
Speight, A. N. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90817-0 · Cited by 67
Changing patterns of antiepileptic drug use in pregnant Australian women
Vajda, F. J. E., Hollingworth, S., Graham, J. E., Hitchcock, A. A., O’Brien, T. J., Lander, C. M., & Eadie, M. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01260.x · Cited by 67
Biswas, P. N., Wilton, L., Pearce, G. L., Freemantle, S. N., & Shakir, S. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500405 · Cited by 67
Fertility of psychiatric first admissions in Norway 1936–1975
ØDegarrd, Ø. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1980.tb00609.x · Cited by 67
A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome
Hall, E. S., Isemann, B. T., Wexelblatt, S. L., Meinzen‐Derr, J. K., Wiles, J. R., Harvey, S., & Akinbi, H. T. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.039 · Cited by 67
Maternal psychotropic medication and neonatal behavior
Auerbach, J. G., Hans, S. L., Marcus, J. H., & Maeir, S. (1992) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(92)90050-k · Cited by 66
Strengths and limitations of the Apgar score: A critical appraisal
Schmidt, B. K., Kirpalani, H., Rosenbaum, P., & Cadman, D. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90100-x · Cited by 66
Relationship between Maternal Methadone Dose at Delivery and Neonatal Abstinence Syndrome
Seligman, N. S., Almario, C. V., Hayes, E. J., Dysart, K. C., Berghella, V., & Baxter, J. K. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.03.033 · Cited by 66
Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate
Ebbesen, F. (2000) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.83.2.f124 · Cited by 66
Antidepressant Use During Pregnancy: Current Controversies and Treatment Strategies
PAYNE, J. L., & MELTZER-BRODY, S. (2009) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181b52e20 · Cited by 64
Clozapine Use in Two Full-Term Pregnancies
Stoner, S. C., Sommi, R. W., Marken, P. A., Anya, I., & Vaughn, J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0806f · Cited by 64
Behavioral effects of perinatal opioid exposure
Fodor, A., Tímár, J., & Zelena, D. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.04.006 · Cited by 63
Side effects of phenobarbital in epilepsy: a systematic review
Zhang, L., Zeng, L., & Li, Y. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0444 · Cited by 61
The Effect of Methadone Dose Regimen on Neonatal Abstinence Syndrome
McCarthy, J. J., Leamon, M. H., Willits, N. H., & Salo, R. E. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000099 · Cited by 61
Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome
Kraft, W. K., & van den Anker, J. N. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.07.006 · Cited by 60
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.11.1395 · Cited by 59
Antiepileptic drug use by pregnant women enrolled in Florida Medicaid
Wen, X., Meador, K. J., & Hartzema, A. G. (2015) · Neurology · doi:10.1212/wnl.0000000000001304 · Cited by 59
Women with nonorganic psychosis: pregnancy's effect on mental health during pregnancy
McNeil, T. F., Kaij, L., & Maimquist‐Larsson, A. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb01191.x · Cited by 58
Gender Aspects of Pharmacokinetics of New and Old AEDs
Tomson, T. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000179843.63515.8f · Cited by 57
Lendoiro, E., Colmenero, E. G., Concheiro‐Guisán, A., de Castro, A., Cruz, A., López‐Rivadulla, M., & Concheiro, M. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318288453f · Cited by 57
Neonatal convulsions after withdrawal of baclofen
Ratnayaka, B. D. M., Dhaliwal, H. S., & Watkin, S. (2001) · BMJ · doi:10.1136/bmj.323.7304.85 · Cited by 56
The EURAP Study Group (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02093.x · Cited by 56
Effect of Diazepam Administered to Mothers During Labour on Temperature Regulation of Neonate
Owen, J. R., Irani, S. F., & Blair, A. W. (1972) · Archives of Disease in Childhood · doi:10.1136/adc.47.251.107 · Cited by 55
Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops
Langenfeld, S., Birkenfeld, L., Herkenrath, P., Müller, C., Hellmich, M., & Theisohn, M. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.001 · Cited by 54
Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs.
(1998) · PubMed · Cited by 54
Physical dependence produced by central morphine infusions: An anatomical mapping study
Bozarth, M. A. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90050-7 · Cited by 53
Warren, M. D., Miller, A. M., Traylor, J., Bauer, A. M., & Patrick, S. W. (2015) · PubMed Central · Cited by 52
Haddad, P. M., Pal, B. R., Clarke, P., Wieck, A., & Sridhiran, S. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105056554 · Cited by 51
Effects of maternal oral morphine consumption on neural tube development in Wistar rats
Nasiraei-Moghadam, S., Sahraei, H., Bahadoran, H., Sadooghi, M., Salimi, S. H., Kaka, G. R., Imani, H., Mahdavinasab, H., & Dashtnavard, H. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.06.012 · Cited by 49
Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
Klinger, G., & Merlob, P. (2008) · PubMed · Cited by 49
Increasing use of atypical antipsychotics and anticonvulsants during pregnancy
EPSTEIN, R. A., Bobo, W. V., Shelton, R. C., Arbogast, P. G., Morrow, J., Wang, W., Chandrasekhar, R., & Cooper, W. O. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3366 · Cited by 48
Gabapentin withdrawal syndrome in the presence of a taper
Tran, K. T., Hranicky, D., Lark, T., & JACOB, N. J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00200.x · Cited by 48
Use of Duloxetine in Pregnancy and Lactation
BRIGGS, G. G., Ambrose, P. J., llett, K. F., Hackett, L. P., Nageotte, M. P., & Padilla, G. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m317 · Cited by 48
Fetal phenytoin exposure, hypoplastic nails, and jitteriness.
D'Souza, S. W., Robertson, I. G., Donnai, D., & Mawer, G. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.3.320 · Cited by 46
INTRAUTERINE EFFECT OF PHENOTHIAZINES
O'Connor, M., Johnson, G. H., & James, D. I. (1981) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1981.tb135684.x · Cited by 46
Diazepam (valium) as an adjunct in obstetric analgesia.
Ce, F., Rudolph, A. J., & Mm, D. (1969) · PubMed · Cited by 46
(2015) · PubMed Central · Cited by 45
Outcome of Infants Exposed to Olanzapine During Breastfeeding
Gilad, O., Merlob, P., Stahl, B., & Klinger, G. (2010) · Breastfeeding Medicine · doi:10.1089/bfm.2010.0027 · Cited by 45
Retentissement néonatal de l'exposition aux benzodiazépines en fin de grossesse
Swortfiguer, D., Cissoko, H., Giraudeau, B., Jonville-Béra, A. P., Bensouda, L., & Autret-Leca, E. (2005) · Archives de Pédiatrie · doi:10.1016/j.arcped.2005.03.055 · Cited by 43
Discontinuation of Phenytoin, Carbamazepine, and Valproate in Patients with Active Epilepsy
Duncan, J. S., Shorvon, S. D., & Trimble, M. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05383.x · Cited by 43
Possible neonatal diazepam withdrawal: A case report
Mazzi, E. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90102-8 · Cited by 42
Women with nonorganic psychosis: factors associated with pregnancy's effect on mental health
McNeil, T. F., Kaij, L., & Malmquist‐Larsson, A. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb01200.x · Cited by 42
Barbiturate Withdrawal Syndrome in a Passively Addicted Infant
Bleyer, W. A. (1972) · JAMA · doi:10.1001/jama.1972.03200150049012 · Cited by 42
PLOMAN, L., & PERSSON, B. H. (1957) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1957.tb08460.x · Cited by 42
Effects of in Utero Antiepileptic Drug Exposure
Meador, K. J. (2008) · Epilepsy Currents · doi:10.1111/j.1535-7511.2008.00273.x · Cited by 42 · cited 1×
“Newer AEDs appear to be safer in pregnancy compared with older AEDs, even though limited data makes it difficult to issue solid recommendations [163, 167, 168].”
BackgroundMaternal methadone therapy increases QTc interval in newborn infants: Table 1
Parikh, R., Hussain, T., Holder, G., Bhoyar, A., & Ewer, A. K. (2010) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2009.181701 · Cited by 41
Neonatal Codeine Withdrawal in Infants of Nonaddicted Mothers
Mangurten, H. H., & Benawra, R. S. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.159 · Cited by 40
Duloxetine transfer across the placenta during pregnancy and into milk during lactation
Boyce, P. M., Hackett, L. P., & Ilett, K. F. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-011-0215-5 · Cited by 40
Neonatal Gabapentin Withdrawal Syndrome
Carrasco, M., Rao, S. C., Bearer, C. F., & Sundararajan, S. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.06.023 · Cited by 40
Clozapine and lorazepam administration in pregnancy
Michele, V. D., Ramenghi, L. A., & Sabatino, G. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)88396-9 · Cited by 39
Obstetrical and Neonatal Outcome following Clonazepam Use during Pregnancy: A Case Series
Weinstock, L., Cohen, L. S., Bailey, J. W., Blatman, R., & Rosenbaum, J. F. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056242 · Cited by 39
Ishizaki, T., Yokochi, K., Chiba, K., Tabuchi, T., & Wagatsuma, T. (1981) · PubMed · Cited by 39
Atypical Antipsychotics for the Treatment of Bipolar Disorder: More Shadows than Lights
Gentile, S. (2007) · CNS Drugs · doi:10.2165/00023210-200721050-00002 · Cited by 37
The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation.
Iqbal, M. M., Aneja, A., Rahman, A., Megna, J. L., Freemont, W., Shiplo, M., Nihilani, N., & Lee, K. (2005) · PubMed Central · Cited by 37
Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia
Kim, S., Kim, K.-M., Kim, J., Shin, I., Shin, H., Yang, S., & Yoon, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.017 · Cited by 37
Pharmacological Aspects of Neonatal Antidepressant Withdrawal
ter Horst, P. G. J., Jansman, F. G. A., van Lingen, R. A., Smit, J.-P., de Jong-van den Berg, L. T. W., & Brouwers, J. R. B. J. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181676be8 · Cited by 37
Neonatal Withdrawal Syndrome Associated With Hydroxyzine Hydrochloride
Prenner, B. M. (1977) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1977.02120180043007 · Cited by 37
Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy
Regan, J., Chambers, F., Gorman, W. A., & MacSullivan, R. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb13282.x · Cited by 37
EXPOSURE TO BENZODIAZEPINES IN UTERO
Barry, W., Sheri, M., & Clair (1987) · The Lancet · doi:10.1016/s0140-6736(87)90629-5 · Cited by 36
BLOOD LEVELS OF D1AZEPAM IN INFANTS OF TWO MOTHERS GIVEN LARGE DOSES OF DIAZEPAM DURING LABOUR
McCarthy, G. T., O'Connell, B., & Robinson, A. E. (1973) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1973.tb11206.x · Cited by 36
Koch, S., Göpfert-Geyer, I., Jäger-Roman, E., Jakob, S., Huth, H., Hartmann, A., Rating, D., & Helge, H. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1069536 · Cited by 35
A STUDY OF THE PLASMA CONCENTRATIONS OF LORAZEPAM IN MOTHER AND NEONATE
MCBRIDE, R. J., DUNDEE, J. W., MOORE, J., TONER, W., & HOWARD, P. J. (1979) · British Journal of Anaesthesia · doi:10.1093/bja/51.10.971 · Cited by 35
Research works printed but not linked: 5
- 234. Gonzalez de Dios J, Moya-Benavent M, Carratala-Marco F. ["Floppy infant" syndrome in twins secondary to the use of benzodiazepines during pregnancy]. Revista de neurologia. 1999;29(2):121-3.
- 258. Taylor D, Paton, C., & Kapur, S. . Prescribing guidelines in psychiatry (11th ed.). CornWall, UK: A John Wiley & Sons. 2012.
- 284. S. B. Psychotropic Drug Directory. . Salisbury, UK: Fivepin Limited; . 2005;235.
- 285. Dev VJ KP. Adverse event profile and safety of clozapine. . Rev Contemp Pharmacother. 1995;6:197208.
- 286. Vavrusova L KM. Clozapine administration during pregnancy [in Czechoslovakian]. . Ceska Slov Psychiatr 1998;94:282-5.
Cited by
An advanced human in vitro co-culture model for translocation studies across the placental barrier
Aengenheister, L., Keevend, K., Muoth, C., Schönenberger, R., Diener, L., Wick, P., & Buerki-Thurnherr, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-23410-6 · Cited by 121
Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies
Raffaeli, G., Cavallaro, G., Allegaert, K., Wildschut, E. D., Fumagalli, M., Agosti, M. A., Tibboel, D., & Mosca, F. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1954 · Cited by 69
“At delivery time, the decrease of serotonin transmission, as a consequence of both SNRI and SSRI discontinuation and receptor desensitization, has an impact on the other pathways involved.(29) For those neonates whose mothers use TCAs, withdrawal symptoms result from a “cholinergic overdrive phenomenon,” promoted by t…”
BackgroundInfluentialBrunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“184,185 Both neonatal BZD withdrawal and FIS typically present within the first hours of life and continue for up to 14 days.”
Umer, A., Loudin, S., Maxwell, S. R., Lilly, C. L., Stabler, M. E., Cottrell, L., Hamilton, C., Breyel, J., Mullins, C., & John, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0172-z · Cited by 27
Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20166565 · Cited by 17
“The onset and duration of symptoms correlate with the pharmacokinetics and placental disposition of benzodiazepines [227].”
Background
Metadata
- Authors
- Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Tuccori, Marco
- Venue
- Drug Safety
- Published
- 2016-10
- Volume
- 39
- Issue
- 10
- Pages
- 903-924
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W2409304735
- Cited by
- 32
- References
- 315
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 3
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- green
- link.springer.com
- Licence
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
- Electronic Theses and Dissertations Repository (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- neonatal abstinence syndrome, withdrawal syndrome, psychotropic drugs, opioids, antidepressants, antiepileptic drugs, antipsychotic drugs, neonatal feeding disorders, adverse drug reaction reporting
- MeSH terms
- Adaptation, Physiological, Female, Humans, Infant, Newborn, Neonatal Abstinence Syndrome, Pregnancy, Psychotropic Drugs, Prescription Drugs, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.